Cargando…

Impact of new UK (B.1.1.7) SARS-Cov-2 variant on interacting with ACE2 and host immune response

Detalles Bibliográficos
Autores principales:	Paniri, Alireza, Hosseini, Mohammad Mahdi, Akhavan-Niaki, Haleh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414842/ https://www.ncbi.nlm.nih.gov/pubmed/34493993 http://dx.doi.org/10.1016/j.genrep.2021.101342

Ejemplares similares

Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations
por: Paniri, Alireza, et al.
Publicado: (2021)

Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations
por: Paniri, Alireza, et al.
Publicado: (2020)

Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
por: Paniri, Alireza, et al.
Publicado: (2020)

SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
por: Thorne, Lucy G, et al.
Publicado: (2021)

Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital trust
por: Garvey, Mark I., et al.
Publicado: (2021)

In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
por: Villoutreix, Bruno O., et al.
Publicado: (2021)

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
por: Hill, Verity, et al.
Publicado: (2022)

First detection of SARS-CoV-2 variant B.1.1.7 in Senegal
por: Padane, A., et al.
Publicado: (2021)

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
por: Chen, Chaoran, et al.
Publicado: (2021)

Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2022)

Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK
por: Kow, Chia Siang, et al.
Publicado: (2021)

Correction to: The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Publicado: (2022)

The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021)

Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
por: van Ogtrop, M. L., et al.
Publicado: (2021)

Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022)

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
por: Wang, Pengfei, et al.
Publicado: (2021)

Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
por: Reuschl, Ann-Kathrin, et al.
Publicado: (2021)

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
por: Brookman, Sarah, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy
por: Lo Menzo, Sara, et al.
Publicado: (2021)

Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages
por: Jewell, Britta L
Publicado: (2021)

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
por: Zhang, Jingsong, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Mitchell, Patrick K., et al.
Publicado: (2021)

Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
por: Michaelsen, Thomas Y., et al.
Publicado: (2022)

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
por: Zárate, Selene, et al.
Publicado: (2022)

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out
por: Giles, Benjamin, et al.
Publicado: (2021)

Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
por: Khalid, Muhammad Faran, et al.
Publicado: (2021)

Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt
por: Seadawy, Mohamed G., et al.
Publicado: (2022)

Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
por: Lee, Hye Kyung, et al.
Publicado: (2021)

Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7
por: Peters, Michael H., et al.
Publicado: (2021)

Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein
por: Borocci, Stefano, et al.
Publicado: (2021)

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia, et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia R., et al.
Publicado: (2021)

Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32fa9vfe1sr2bm9db6jsret58f